Pausing COVID-19 vaccine rollouts can backfire. There are better ways to manage safety issues while they’re being investigated.
Articles on Vaccine hesitancy
Displaying 181 - 200 of 251 articles
These results can help allay previous concerns in Europe about a lack of trial data for older people.
Surveys suggest people trust companies more than government and the media, showing they have an important role in helping end the pandemic.
Allowing people to discuss their concerns one-on-one has been shown the improve vaccine uptake.
Divisions among Catholics have created doubts about the moral acceptability of one of the COVID-19 vaccines. An expert explains why there isn’t one ‘Catholic view’ on the issue.
From Queen Elizabeth to Willie Nelson, celebrities have long used their platforms to promote public health information. Why do people trust celebrities for health advice more than the government?
Stockpiles of this vaccine are going unused in France and Germany, and unfounded criticism of it may be partly to blame.
For anyone who has worked on crop improvement in Africa over the last three decades, the flood of misinformation around vaccines evokes an eerie sense of déjà vu.
As New Zealand prepares to roll out COVID-19 vaccines to the general population, health authorities will need to reach those who remain hesitant through information sources they trust.
Vaccination has been controversial from its beginning. Gaining people’s trust in vaccines has been crucial. An important part of that is a strong communications plan.
Our new research found gaps in COVID information available to culturally and linguistically diverse communities. But there are ways we can improve — because community ownership is crucial.
We analysed the public communication strategies that Australia and France used to promote childhood immunisation. There are lessons to be learned for the government’s current COVID vaccine campaign.
Though COVID-19 has killed Black Americans at nearly twice the rate as white Americans, Black people are the least likely racial group to say they’re eager to get the vaccine.
Roald Dahl’s daughter Olivia died of measles aged seven.
With a third of adults saying they likely won’t get the vaccine, the US has a herd immunity math problem.
How will governments convince enough people to get vaccinated to achieve herd immunity?
The pandemic will not end for anyone, anywhere until it is controlled in every country. Tanzania’s approach will make it that much harder for normality to return.
One university is showing how the vaccine corps concept can speed up vaccination rates, including launching a large-scale vaccination site staffed by hundreds of students and volunteers.
Women, particularly those of childbearing age, were more likely to be unsure about getting vaccinated.
Vaccine hesitancy will not go away fast. In fact, there are parallels in the physical world to how quickly or slowly an object returns to its normal state.
Top contributors
-
Associate Professor of Health Law, Policy and Management, Boston University
-
Professor, School of Population Health, UNSW
-
Professor of Paediatrics and vaccinologist, Royal Childrens Hospital, University of Melbourne and Murdoch Childrens Research Institute (MCRI); Associate Dean International, University of Melbourne, Murdoch Children's Research Institute
-
Research Fellow, Vaccine Uptake Group, Murdoch Children's Research Institute
-
Professor, School of Public Health, University of Sydney
-
Professor, School of Social Sciences, The University of Western Australia
-
Extraordinary Professor, Global Health, Stellenbosch University; South African Medical Research Council
-
Endowed Professor of Health Policy and Associate Dean, George Washington University
-
Assistant Professor of Communication and Political Science, The Ohio State University
-
Senior Scientist, Cochrane South Africa, South African Medical Research Council (SAMRC) and Honorary researcher, Division of Social & Behavioural Sciences, School of Public Health, UCT, South African Medical Research Council
-
Professor of Neurology, Medicine (Infectious Diseases), and Epidemiology, University of Colorado Anschutz
-
Executive Director, African Population and Health Research Center
-
Senior Lecturer, School of Communication, Journalism and Marketing, Te Kunenga ki Pūrehuroa – Massey University
-
Assistant Professor of Health Policy and Managment, School of Public Health, Texas A&M University
-
Postdoctoral Research Associate in Public Interest Communications, University of Florida